Malcolm Skingle
Director, Academic Liaison, GlaxoSmithKline
Malcolm has a BSc in Pharmacology/Biochemistry and PhD in Neuropharmacology and has over 60 publications including articles on the interface between industry and academia. He currently manages GSK’s Academic Liaison, with staff in the US and UK. His role involves close liaison with several groups outside the company including Government Departments, Research and Funding Councils. He sits on many external bodies including BBSRC Council, HEFCE REF Main Panel A and several UK University Department advisory groups. Malcolm chairs several groups including the Diamond (Synchotron) Industrial Advisory Board, the Science Industry Partnership and the ABPI academic liaison group.
Malcolm's address will cover, 'The Triple Helix: Working Together to Innovate.'